Clarissa Oriel Rhines

Title: Clarissa Oriel Rhines: Innovator in CRISPR Technology

Introduction

Clarissa Oriel Rhines is a prominent inventor based in San Mateo, California. She has made significant contributions to the field of biotechnology, particularly in the development of effector proteins associated with CRISPR technology. With a total of two patents to her name, Rhines is recognized for her innovative approaches to genetic engineering.

Latest Patents

Rhines' latest patents focus on effector proteins and their methods of use. These patents describe compositions, systems, and methods that utilize effector proteins, which are shown to be active with guide RNAs and characterized as CRISPR-associated (Cas) proteins. The disclosed technologies leverage the activities of these effector proteins for the modification, detection, and engineering of nucleic acids, showcasing her expertise in this cutting-edge area of research.

Career Highlights

Clarissa Rhines is currently employed at Mammoth Biosciences, Inc., where she continues to advance her research in biotechnology. Her work has positioned her as a key figure in the development of innovative solutions that harness the power of CRISPR technology.

Collaborations

Throughout her career, Rhines has collaborated with notable colleagues, including Aaron DeLoughery and Lucas Benjamin Harrington. These partnerships have contributed to her success and the advancement of her research initiatives.

Conclusion

Clarissa Oriel Rhines is a trailblazer in the field of biotechnology, particularly in the realm of CRISPR technology. Her patents and work at Mammoth Biosciences, Inc. reflect her commitment to innovation and scientific advancement.